MMP generated matrikines

Matrix Biology

Volumn 44-46, Issue , 2015, Pages 122-129

  Wells, J Michael ^a,b,c   Gaggar, Amit ^a,b,c   Blalock, J Edwin ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

COPD; Elastin; Matrix metalloproteinase; Proline glycine proline

Indexed keywords

CIGARETTE SMOKE; ELASTIN; GELATINASE A; GELATINASE B; GLYCINE; INTERSTITIAL COLLAGENASE; LEUKOTRIENE A4 HYDROLASE; MACROPHAGE ELASTASE; MATRIKINE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; PROLINE; SCLEROPROTEIN; UNCLASSIFIED DRUG; OLIGOPEPTIDE; PEPTIDE; VALYL-ALANYL-PROLYL-GLYCINE;

ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORNEA ULCER; EXTRACELLULAR MATRIX; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; TUMOR INVASION; ANIMAL; INFLAMMATION; METABOLISM;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; INFLAMMATION; MATRIX METALLOPROTEINASES; OLIGOPEPTIDES; PEPTIDES;

EID: 84930755259     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.01.016     Document Type: Review

References (73)

1. Duca L., Floquet N., Alix A.J., Haye B., Debelle L. Elastin as a matrikine. Crit Rev Oncol Hematol 2004, 49:235-244.
2. Weathington N.M., van Houwelingen A.H., Noerager B.D., Jackson P.L., Kraneveld A.D., Galin F.S., et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2006, 12:317-323.
3. Yamanaka O., Sumioka T., Saika S. The role of extracellular matrix in corneal wound healing. Cornea 2013, 32(Suppl. 1):S43-S45.
4. Tran K.T., Griffith L., Wells A. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen 2004, 12:262-268.
5. Ramont L., Brassart-Pasco S., Thevenard J., Deshorgue A., Venteo L., Laronze J.Y., et al. The NC1 domain of type XIX collagen inhibits in vivo melanoma growth. Mol Cancer Ther 2007, 6:506-514.
6. Arul V., Gopinath D., Gomathi K., Jayakumar R. Biotinylated GHK peptide incorporated collagenous matrix: a novel biomaterial for dermal wound healing in rats. J Biomed Mater Res B Appl Biomater 2005, 73:383-391.
7. Luikart S.D., Panoskaltsis-Mortari A., Hinkel T., Perri R.T., Gupta K., Oegema T.R., et al. Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation. BMC Cell Biol 2009, 10:60.
8. Brassart-Pasco S., Senechal K., Thevenard J., Ramont L., Devy J., Di Stefano L., et al. Tetrastatin, the NC1 domain of the alpha4(IV) collagen chain: a novel potent anti-tumor matrikine. PLoS One 2012, 7:e29587.
9. Kao W.W. Ocular surface tissue morphogenesis in normal and disease states revealed by genetically modified mice. Cornea 2006, 25:S7-S19.
10. Yamanaka O., Yuan Y., Coulson-Thomas V.J., Gesteira T.F., Call M.K., Zhang Y., et al. Lumican binds ALK5 to promote epithelium wound healing. PLoS One 2013, 8:e82730.
11. Tran K.T., Lamb P., Deng J.S. Matrikines and matricryptins: implications for cutaneous cancers and skin repair. J Dermatol Sci 2005, 40:11-20.
12. Vassiliadis E., Barascuk N., Didangelos A., Karsdal M.A. Novel cardiac-specific biomarkers and the cardiovascular continuum. Biomark Insights 2012, 7:45-57.
13. Ra H.J., Parks W.C. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007, 26:587-596.
14. Vrhovski B., Weiss A.S. Biochemistry of tropoelastin. Eur J Biochem 1998, 258:1-18.
15. Bashir M.M., Indik Z., Yeh H., Ornstein-Goldstein N., Rosenbloom J.C., Abrams W., et al. Characterization of the complete human elastin gene. Delineation of unusual features in the 5'-flanking region. J Biol Chem 1989, 264:8887-8891.
16. Wirtschafter Z.T., Cleary E.G., Jackson D.S., Sandberg L.B. Histological changes during the development of the bovine nuchal ligament. J Cell Biol 1967, 33:481-488.
17. Werb Z., Banda M.J., McKerrow J.H., Sandhaus R.A. Elastases and elastin degradation. J Invest Dermatol 1982, 79(Suppl. 1):154s-159s.
18. Senior R.M., Griffin G.L., Mecham R.P., Wrenn D.S., Prasad K.U., Urry D.W. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol 1984, 99:870-874.
19. Bisaccia F., Morelli M.A., De Biasi M., Traniello S., Spisani S., Tamburro A.M. Migration of monocytes in the presence of elastolytic fragments of elastin and in synthetic derivates. Structure-activity relationships. Int J Pept Protein Res 1994, 44:332-341.
20. Price L.S., Roos P.J., Shively V.P., Sandberg L.B. Valyl-alanyl-prolyl-glycine (VAPG) serves as a quantitative marker for human elastins. Matrix 1993, 13:307-311.
21. Wachi H., Seyama Y., Yamashita S., Suganami H., Uemura Y., Okamoto K., et al. Stimulation of cell proliferation and autoregulation of elastin expression by elastin peptide VPGVG in cultured chick vascular smooth muscle cells. FEBS Lett 1995, 368:215-219.
22. Nackman G.B., Karkowski F.J., Halpern V.J., Gaetz H.P., Tilson M.D. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. Surgery 1997, 122:39-44.
23. Faury G., Garnier S., Weiss A.S., Wallach J., Fulop T., Jacob M.P., et al. Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca2+ level in human vascular endothelial cells. Circ Res 1998, 82:328-336.
24. Wasano K., Hirakawa Y., Nakamura K. Immunolocalization of 67kDa elastin-binding protein in perinatal rat lungs. Cell Tissue Res 1992, 268:277-281.
25. Hinek A., Boyle J., Rabinovitch M. Vascular smooth muscle cell detachment from elastin and migration through elastic laminae is promoted by chondroitin sulfate-induced "shedding" of the 67-kDa cell surface elastin binding protein. Exp Cell Res 1992, 203:344-353.
26. Senior R.M., Griffin G.L., Mecham R.P. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980, 66:859-862.
27. Dupont A., Dury S., Gafa V., Lebargy F., Deslee G., Guenounou M., et al. Impairment of neutrophil reactivity to elastin peptides in COPD. Thorax 2013, 68:421-428.
28. Hunninghake G.W., Davidson J.M., Rennard S., Szapiel S., Gadek J.E., Crystal R.G. Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science 1981, 212:925-927.
29. Chang C.H., Kawa Y., Tsai R.K., Shieh J.H., Lee J.W., Watabe H., et al. Melanocyte precursors express elastin binding protein and elastin-derived peptide (VGVAPG) stimulates their melanogenesis and dendrite formation. J Dermatol Sci 2008, 51:158-170.
30. Blood C.H., Sasse J., Brodt P., Zetter B.R. Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol 1988, 107:1987-1993.
31. Blood C.H., Zetter B.R. Membrane-bound protein kinase C modulates receptor affinity and chemotactic responsiveness of Lewis lung carcinoma sublines to an elastin-derived peptide. J Biol Chem 1989, 264:10614-10620.
32. Toupance S., Brassart B., Rabenoelina F., Ghoneim C., Vallar L., Polette M., et al. Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA. Clin Exp Metastasis 2012, 29:511-522.
33. Donet M., Brassart-Pasco S., Salesse S., Maquart F.X., Brassart B. Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependent mechanism. Br J Cancer 2014, 111:139-148.
34. Pocza P., Suli-Vargha H., Darvas Z., Falus A. Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. Int J Cancer 2008, 122:1972-1980.
35. Debret R., Le Naour R.R., Sallenave J.M., Deshorgue A., Hornebeck W.G., Guenounou M., et al. Elastin fragments induce IL-1beta upregulation via NF-kappaB pathway in melanoma cells. J Invest Dermatol 2006, 126:1860-1868.
36. Brassart B., Fuchs P., Huet E., Alix A.J., Wallach J., Tamburro A.M., et al. Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem 2001, 276:5222-5227.
37. Blanchevoye C., Floquet N., Scandolera A., Baud S., Maurice P., Bocquet O., et al. Interaction between the elastin peptide VGVAPG and human elastin binding protein. J Biol Chem 2013, 288:1317-1328.
38. Ishii T., Asuwa N. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Hum Pathol 2000, 31:640-646.
39. Ishii T., Asuwa N. Spiraled collagen in the major blood vessels. Mod Pathol 1996, 9:843-848.
40. Boyle J.R., McDermott E., Crowther M., Wills A.D., Bell P.R., Thompson M.M. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg 1998, 27:354-361.
41. Mecham R.P., Broekelmann T.J., Fliszar C.J., Shapiro S.D., Welgus H.G., Senior R.M. Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J Biol Chem 1997, 272:18071-18076.
42. Houghton A.M., Quintero P.A., Perkins D.L., Kobayashi D.K., Kelley D.G., Marconcini L.A., et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006, 116:753-759.
43. Hautamaki R.D., Kobayashi D.K., Senior R.M., Shapiro S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997, 277:2002-2004.
44. He J., Turino G.M., Lin Y.Y. Characterization of peptide fragments from lung elastin degradation in chronic obstructive pulmonary disease. Exp Lung Res 2010, 36:548-557.
45. Lee S.H., Goswami S., Grudo A., Song L.Z., Bandi V., Goodnight-White S., et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007, 13:567-569.
46. Xu C., Hesselbacher S., Tsai C.L., Shan M., Spitz M., Scheurer M., et al. Autoreactive T Cells in human smokers is predictive of clinical outcome. Front Immunol 2012, 3:267.
47. Haddox J.L., Pfister R.R., Muccio D.D., Villain M., Sommers C.I., Chaddha M., et al. Bioactivity of peptide analogs of the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. Invest Ophthalmol Vis Sci 1999, 40:2427-2429.
48. van Houwelingen A.H., Weathington N.M., Verweij V., Blalock J.E., Nijkamp F.P., Folkerts G. Induction of lung emphysema is prevented by L-arginine-threonine-arginine. FASEB J 2008, 22:3403-3408.
49. Braber S., Overbeek S.A., Koelink P.J., Henricks P.A., Zaman G.J., Garssen J., et al. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1. Eur J Pharmacol 2011, 668:443-449.
50. Kim S.D., Lee H.Y., Shim J.W., Kim H.J., Yoo Y.H., Park J.S., et al. Activation of CXCR2 by extracellular matrix degradation product acetylated Pro-Gly-Pro has therapeutic effects against sepsis. Am J Respir Crit Care Med 2011, 184:243-251.
51. Hardison M.T., Brown M.D., Snelgrove R.J., Blalock J.E., Jackson P. Cigarette smoke enhances chemotaxis via acetylation of proline-glycine-proline. Front Biosci (Elite Ed) 2012, 4:2402-2409.
52. Lee Y.C., Jackson P.L., Jablonsky M.J., Muccio D.D., Pfister R.R., Haddox J.L., et al. NMR conformational analysis of cis and trans proline isomers in the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. Biopolymers 2001, 58:548-561.
53. Jackson P.L., Noerager B.D., Jablonsky M.J., Hardison M.T., Cox B.D., Patterson J.C., et al. A CXCL8 receptor antagonist based on the structure of N-acetyl-proline-glycine-proline. Eur J Pharmacol 2011, 668:435-442.
54. Pfister R.R., Haddox J.L., Blalock J.E., Sommers C.I., Coplan L., Villain M. Synthetic complementary peptides inhibit a neutrophil chemoattractant found in the alkali-injured cornea. Cornea 2000, 19:384-389.
55. Haddox J.L., Pfister R.R., Sommers C.I., Blalock J.E., Villain M. Inhibitory effect of a complementary peptide on ulceration in the alkali-injured rabbit cornea. Invest Ophthalmol Vis Sci 2001, 42:2769-2775.
56. Pfister R.R., Sommers C.I. L-arginine-threonine-arginine (RTR) tetramer peptide inhibits ulceration in the alkali-injured rabbit cornea. Cornea 2006, 25:1187-1192.
57. Gaggar A., Jackson P.L., Noerager B.D., O'Reilly P.J., McQuaid D.B., Rowe S.M., et al. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol 2008, 180:5662-5669.
58. Hardison M.T., Galin F.S., Calderon C.E., Djekic U.V., Parker S.B., Wille K.M., et al. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation. J Immunol 2009, 182:4423-4431.
59. Braber S., Koelink P.J., Henricks P.A., Jackson P.L., Nijkamp F.P., Garssen J., et al. Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown. Am J Physiol Lung Cell Mol Physiol 2011, 300:L255-L265.
60. Wells J.M., O'Reilly P.J., Szul T., Sullivan D.I., Handley G., Garrett C., et al. An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014, 190:51-61.
61. O'Reilly P.J., Hardison M.T., Jackson P.L., Xu X., Snelgrove R.J., Gaggar A., et al. Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen. J Neuroimmunol 2009, 217:51-54.
62. Overbeek S.A., Braber S., Koelink P.J., Henricks P.A., Mortaz E., LoTam Loi A.T., et al. Cigarette smoke-induced collagen destruction; key to chronic neutrophilic airway inflammation?. PLoS One 2013, 8:e55612.
63. Snelgrove R.J., Jackson P.L., Hardison M.T., Noerager B.D., Kinloch A., Gaggar A., et al. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science 2010, 330:90-94.
64. Lin M., Jackson P., Tester A.M., Diaconu E., Overall C.M., Blalock J.E., et al. Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro. Am J Pathol 2008, 173:144-153.
65. O'Reilly P., Jackson P.L., Noerager B., Parker S., Dransfield M., Gaggar A., et al. N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respir Res 2009, 10:38.
66. Xu X., Jackson P.L., Tanner S., Hardison M.T., Abdul Roda M., Blalock J.E., et al. A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation. PLoS One 2011, 6:e15781.
67. Adair-Kirk T.L., Atkinson J.J., Kelley D.G., Arch R.H., Miner J.H., Senior R.M. A chemotactic peptide from laminin alpha 5 functions as a regulator of inflammatory immune responses via TNF alpha-mediated signaling. J Immunol 2005, 174:1621-1629.
68. Horejs C.M., Serio A., Purvis A., Gormley A.J., Bertazzo S., Poliniewicz A., et al. Biologically-active laminin-111 fragment that modulates the epithelial-to-mesenchymal transition in embryonic stem cells. Proc Natl Acad Sci U S A 2014, 111:5908-5913.
69. Hamano Y., Zeisberg M., Sugimoto H., Lively J.C., Maeshima Y., Yang C., et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 2003, 3:589-601.
70. Nikolova A., Ablasser K., Wyler von Ballmoos M.C., Poutias D., Kaza E., McGowan F.X., et al. Endogenous angiogenesis inhibitors prevent adaptive capillary growth in left ventricular pressure overload hypertrophy. Ann Thorac Surg 2012, 94:1509-1517.
71. O'Reilly M.S., Holmgren L., Chen C., Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996, 2:689-692.
72. Bergers G., Javaherian K., Lo K.M., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999, 284:808-812.
73. Snelgrove R., Kheradmand F. Leukotriene A4 hydrolase: the Janus enzyme shows its ugly side in smokers. Am J Respir Crit Care Med 2014, 190:5-7.